These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3017345)

  • 1. Destabilization of target-sensitive immunoliposomes by antigen binding--a rapid assay for virus.
    Ho RJ; Rouse BT; Huang L
    Biochem Biophys Res Commun; 1986 Jul; 138(2):931-7. PubMed ID: 3017345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of target-sensitive immunoliposomes with herpes simplex virus. The foundation of a sensitive immunoliposome assay for the virus.
    Ho RJ; Rouse BT; Huang L
    J Biol Chem; 1987 Oct; 262(29):13979-84. PubMed ID: 2820988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic and ultrastructural studies of interactions of target-sensitive immunoliposomes with herpes simplex virus.
    Ho RJ; Ting-Beall HP; Rouse BT; Huang L
    Biochemistry; 1988 Jan; 27(1):500-6. PubMed ID: 2831962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target-sensitive immunoliposomes: preparation and characterization.
    Ho RJ; Rouse BT; Huang L
    Biochemistry; 1986 Sep; 25(19):5500-6. PubMed ID: 3022792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable target-sensitive immunoliposomes.
    Pinnaduwage P; Huang L
    Biochemistry; 1992 Mar; 31(11):2850-5. PubMed ID: 1372514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of drug loaded immunoliposomes to herpes simplex virus infected corneal cells: an effective means of inhibiting virus replication in vitro.
    Norley SG; Huang L; Rouse BT
    J Immunol; 1986 Jan; 136(2):681-5. PubMed ID: 3001182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target-sensitive immunoliposomes as an efficient drug carrier for antiviral activity.
    Ho RJ; Rouse BT; Huang L
    J Biol Chem; 1987 Oct; 262(29):13973-8. PubMed ID: 2820987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of herpes simplex virus replication in the mouse cornea by drug containing immunoliposomes.
    Norley SG; Sendele D; Huang L; Rouse BT
    Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):591-5. PubMed ID: 3030960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of polyethyleneglycol (PEG)-derived lipid on the activity of target-sensitive immunoliposome.
    Ng K; Zhao L; Liu Y; Mahapatro M
    Int J Pharm; 2000 Jan; 193(2):157-66. PubMed ID: 10606778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
    Ritchie MH; Oakes JE; Lausch RN
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid composition is important for highly efficient target binding and retention of immunoliposomes.
    Maruyama K; Kennel SJ; Huang L
    Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5744-8. PubMed ID: 2377612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of antigen-sensitized liposomes with immobilized antibody: a homogeneous solid-phase immunoliposome assay.
    Ho RJ; Huang L
    J Immunol; 1985 Jun; 134(6):4035-40. PubMed ID: 3886794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and characterization of an anti-idiotypic antibody specific for a monoclonal antibody to glycoprotein D of herpes simplex virus.
    Lathey JL; Rouse BT; Wiley DE; Courtney RJ
    Immunology; 1986 Jan; 57(1):29-35. PubMed ID: 3002969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo induction of anti-herpes simplex virus immune response by type 1 antigens and lipid A incorporated into liposomes.
    Naylor PT; Larsen HS; Huang L; Rouse BT
    Infect Immun; 1982 Jun; 36(3):1209-16. PubMed ID: 6284643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes.
    Harding JA; Engbers CM; Newman MS; Goldstein NI; Zalipsky S
    Biochim Biophys Acta; 1997 Jul; 1327(2):181-92. PubMed ID: 9271260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoliposome targeting to murine CD4+ leucocytes is dependent on immune status.
    Phillips NC; Gagne L; Tsoukas C; Dahman J
    J Immunol; 1994 Mar; 152(6):3168-74. PubMed ID: 7908302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies.
    Maruyama K; Takizawa T; Yuda T; Kennel SJ; Huang L; Iwatsuru M
    Biochim Biophys Acta; 1995 Mar; 1234(1):74-80. PubMed ID: 7880861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.